Journal Report

Expert Opinion on Drug Safety

Download PDF
Journal Information
Journal Title
Expert Opinion on Drug Safety
Publisher
Taylor and Francis Ltd.
ISSN
1474-0338
E-ISSN
1744-764X
Database
SCOPUS
Domain
Health Sciences, Life Sciences
Classification History
Year A+ A B C
2026 ✓ ✓
2025 ✓ ✓
2024 ✓ ✓
2023 ✓ ✓
2021/2022 ✓ ✓
2020 ✓ ✓
2019 ✓ ✓
2018 ✓
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
A learning pharmacovigilance system for frail patients: integrating real-world data, artificial intelligence, clinical pharmacology and medicines optimization to prevent medication-related harm
Emilio Russo, Antonio Leo, Roberta Roberti et al.
2026-11-14 Pages 1-16
A safety profile on idarucizumab for dabigatran reversal: an update
Jurjen F. Krommenhoek, Jasper A.F. Demandt, Nienke van Rein et al.
2026-11-13 Pages 1-8
Artificial intelligence–driven pharmacovigilance: transforming signal detection, real-world drug safety monitoring, and regulatory decision-making
Sachin Kumar, Saurabh Chaturvedi
2026-11-9 Pages 1-21
Long-term safety of etrasimod in ulcerative colitis: a narrative review
Michael Colwill, Sailish Honap, Fernando Magro et al.
2026-11-5 Pages 1-13
Momelotinib for the treatment of myelofibrosis in patients with moderate-to-severe anemia: a drug safety evaluation
Andrea Duminuco, Patrick Harrington
2026-11-4 Pages 1-6
A look into adverse renal effects of proton pump inhibitors
Marta Fernandez-Arquillue, Samuel J. Martinez-Dominguez, Ángel Lanas
2026-11-1 Pages 1-4
Long-term safety of treatment of hemophilia A: a comprehensive review
Johnny Mahlangu
2026-10-3 Pages 1-16
Tolerance of methotrexate co-administered with pegloticase in patients with uncontrolled gout: overview of the findings from the mirror RCT
Vinicius Domingues, Abdul Abdellatif, Alexis Woods et al.
2026-9-23
A safety review of JAK inhibitors for managing alopecia areata
Kanchalit Thanomkitti, Sofia Spagnolini, Antonella Tosti
2026-9-20 Pages 1-17
Psychedelics in psychiatry: comparative effectiveness, implementation, commercialization and safety lessons learned from intranasal esketamine
Roger S. McIntyre
2026-9-1 Pages 1-3
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: November 14, 2026 19:14